One of the greatest cancer drugs lost its edge. This is why it was vulnerable.
In November, British-Swedish drug giant AstraZeneca published a simple chart in its quarterly earnings presentation that the pharmaceutical industry never saw coming. It showed that 55% of chronic lymphocytic leukemia patients in the U.S. were choosing Calquence, and not Imbruvica, the long-time leading treatment for the disease, when being prescribed a class of drug known […]
Opinion: Cognitive decline in a loved one: how to spot it, what to do
Both as a financial adviser and in my prior role as an attorney, I’ve seen families struggle with cognitive decline of an aging parent. Financial and estate planning can’t take away the heartache, but they can help families avoid some wrenching situations.In this article, I’ll share two scenarios drawn from real-life circumstances I’ve observed. One […]
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
Drug companies planning to raise prices on cancer drugs and other life-saving treatments are justifying the move by claiming it’s necessary to fund research and development, but the claim rings hollow given that they spend more on shareholder rewards than on R&D, according to a new study. Accountable.US, a liberal-leaning consumer-advocacy group, found that in […]